This is a preview of subscription content, log in via an institution to check access.
References
Cooke JP. Chronic arterial occlusive disease: Medical management. In: Cooke JP, Frohlich ED, eds. Current Management of Hypertensive and Vascular Diseases. St. Louis: BC Decker, 1992:203–208.
Cooke JP, Ma AO. Medical therapy of peripheral arterial occlusive disease. In: Gewertz B, ed. Surgical Clinics of North America. Philadelphia: WB Saunders, 1994, in press.
Hertzer NR. The natural history of peripheral vascular disease. Circulation 1991;83:I12-I19.
Eagle NA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk from major vascular surgery. Ann Intern Med 1989;110:859–866.
McPhail N, Calvin JE, Shariatmadar A, Barber GG, Scobie TK. The use of preoperative exercise testing to predict cardiac complications after arterial reconstruction. J Vasc Surg 1988;7:60–68.
Baron JF, Lumdler O, Bertrand M, et al, Dipyridamolethallium scintigraphy and gaited radionuclide angiography to assess cardiac risk for abdominal aortic surgery. N Engl J Med 1994;330:663–669.
Raby KE, Barry J, Craeger MA, et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA 1992;268:222–227.
Anderson F, Wheeler H, Goldberg R, et al. Physician practice in the prevention of venous thromboembolism. Ann Intern Med 1991;115:591–595.
Hull R, Raskob G, Hirsh J. Prophylaxis of venous thromboembolism: An overview. Chest 1986;85:379–383.
Paiement G, Wessinger S, Hughes R, et al. Routine use of adjusted low dose warfarin to prevent venous thromboembolism after hip replacement. J Bone Joint Surg 1993;75A:893–898.
Merli G. Prophylaxis for deep venous thrombosis and pulmonary embolism in surgery. In: Lubin M, Walker H, Smith R, eds. Medical Management of the Surgical Patient. Philadelphia: JB Lippincott 1995:211–227.
Green D, Hirsh J, Heit J, Prins M, Davidson B, Lensing AWA. Low molecular weight heparin: A critical analysis of clinical trials. Pharm Rev 1994;46:89–109.
Lensing AWA, Prins MH, Davidson BL, Hirsh J. Treatment of deep venous trombosis with low-molecular-weight heparins. A meta-analysis. Arch Intern Med 1995;155:601–607.
Hirsh J, Levine MN. Low molecular weight heparin. Blood 1992;79:1–17.
Turpie AGG, Levine MN, Hirsh J, et al. A randomized controlled trial of PK 10169 low-molecular weight heparin (Enoxaparin) for the prevention of deep vein thrombosis in patients undergoing elective hip surgery. N Eng J Med 1986;315:925–929.
Cooke JP, Tsao P. Cytoprotective effects of nitric oxide. Circulation 1993;88:2451–2454.
Cooke JP, Tsao P. Cellular mechanisms of atherogenesis and the effects of nitric oxide. Cur Opin Cardiol 1992;7:799–804.
Cooke JP, Candipan R. Vascular biology of restenosis: Insights for therapeutic strategies. J Intervent Cardiol 1994;6:25–35.
Dzau DJ, Gibbons GH, Cooke HP, Omoigui M. Vascular biology in medicine in the 1990s: Scope, concepts, potentials, and perspectives. Circulation 1993;87:705–719.
Monada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002–2012.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cohen, D.A. Editorial: Expanding the paradigm of thrombocardiology: Peripheral arterial and venous disease. J Thromb Thrombol 3, 29–33 (1996). https://doi.org/10.1007/BF00226407
Issue Date:
DOI: https://doi.org/10.1007/BF00226407